Moss, 29 August 2022
Gentian Diagnostics ASA has today been notified that the following transaction has been completed by a primary insider in Gentian Diagnostics ASA: Frank Frantzen, board member and primary insider in Gentian Diagnostics ASA, has today bought 20,000 shares at an average price of NOK 43.50 per share. After the transaction, Mr. Frantzen holds 20,000 shares in Gentian Diagnostics ASA.
Please refer to the attached notification of trading for further details.
This information is subject to the disclosure requirements in the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Njaal Kind, Group CFO,
njaal.kind@gentian.no,
+47 91 90 65 25